NCT06563674

Brief Summary

Symptoms, such as cough and shortness of breath, are common among patients with pneumoconiosis. Depression and anxiety can be elicited by the symptoms, while avoidance of daily activities is believed to reduce trigger of symptoms. The lung function is then declined and the risk of having stroke and heart failure is increased. The objectives of this 2-arm waitlist pilot randomized controlled trial are to test the effects and feasibility of an acceptance-based educational program among patients with pneumoconiosis. 80 participants will be recruited from community centers and randomly assigned to intervention group or waitlist-control group in a ratio of 1:1. The 6-week group-based educational program will be provided to the intervention group first, then the waitlist-control group. The program consists of 4 sessions integrated with acceptance components and care of pneumoconiosis. Their psychological health, healthy lifestyles, and cardiometabolic profiles will be assessed at baseline, week 6, and week 14. Data will be analyzed using a statistical package. The feasibility of the program will be evaluated by interview. The findings of this study can inform the integration of acceptance-based intervention into pneumoconiosis management in Hong Kong, and future study on chronic progressive lung diseases.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 21, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

April 13, 2025

Status Verified

August 1, 2024

Enrollment Period

9 months

First QC Date

August 13, 2024

Last Update Submit

April 9, 2025

Conditions

Keywords

PneumoconiosisHealthy LifestyleAcceptance-based

Outcome Measures

Primary Outcomes (1)

  • Psychological flexibility

    Measured by Acceptance and Action Questionnaire-II Chinese version. It is a 7-point Likert scale with 7 items. The score ranges from 7 to 49 and a higher total score indicates less flexibility.

    Baseline, week 6, and week 14

Secondary Outcomes (6)

  • Exercise-related outcome

    Baseline, week 6, and week 14

  • Practice of healthy diet

    Baseline, week 6, and week 14

  • Blood pressure

    Baseline, week 6, and week 14

  • Waist circumference

    Baseline, week 6, and week 14

  • Body weight

    Baseline, week 6, and week 14

  • +1 more secondary outcomes

Study Arms (2)

Control

ACTIVE COMPARATOR

Participants will receive the acceptance-based healthy lifestyles program between week 8-14.

Other: Acceptance-based healthy lifestyles program (control group)

Intervention

EXPERIMENTAL

Participants will receive the acceptance-based healthy lifestyles program between week 1-6.

Other: Acceptance-based healthy lifestyles program (intervention group)

Interventions

The acceptance-based healthy lifestyles program consists of 4 biweekly 60-min face-to-face interactive workshops to cover the knowledge of pneumoconiosis, exercise to maintain lung function, health diet, and home safety.

Intervention

The acceptance-based healthy lifestyles program consists of 4 biweekly 60-min face-to-face interactive workshops to cover the knowledge of pneumoconiosis, exercise to maintain lung function, health diet, and home safety.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ethnic Chinese who is able read and speak Chinese.
  • Adults aged 18 or over.
  • Taking compensation for pneumoconiosis.

You may not qualify if:

  • Those who have mental, visual, hearing, or cognitive impairments with regular medical follow-ups and treatment.
  • Those who are unable to give written consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PMAA

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

Pneumoconiosis

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Lung Diseases, InterstitialLung DiseasesRespiratory Tract DiseasesLung InjuryOccupational Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Hon Lon Tam, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The baseline data will be collected by research assistant (RA)1 before randomization, while the follow-ups data will be collected by RA2. The participant's group allocation is masked to the outcome assessors. But the participants know their group allocation after randomization because of the nature of the intervention. Different dates will be planned for different groups for all follow-ups respectively to avoid contamination of the subjects and blinding to the outcome assessors as far as possible
Purpose
OTHER
Intervention Model
SEQUENTIAL
Model Details: A 2-arm waitlist pilot randomized controlled trial will be adopted. After baseline data collection, participants in the intervention group will receive the health program for 6 weeks. On the other hand, participants in the waitlist-control group will receive the same health program week 8 and week 14.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

August 13, 2024

First Posted

August 21, 2024

Study Start

November 1, 2024

Primary Completion

August 1, 2025

Study Completion

January 1, 2026

Last Updated

April 13, 2025

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Available upon request and approval from the funding body.

Locations